1026 Scorpion launch
BioCentury & Getty Images

Emerging Company Profile

Serial dealmaker Glick to lead cancer start-up Scorpion with familiar VCs supplying $108M 

Syndicate that backed IFM invests in experienced precision oncology team

A syndicate including VCs who backed IFM invests in an experienced precision oncology team.

Oct 26, 2020 | 11:55 AM GMT

A VC syndicate that backed IFM and serial dealmaker Gary Glick has launched precision oncology start-up Scorpion, where

Read the full 664 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE